Prevenar 20, Injektionssuspension in einer Fertigspritze

7680692220011 CH-69222 Injektionssuspension
Prevenar 20, Injektionssuspension in einer Fertigspritze
Prevenar 20, Injektionssuspension in einer Fertigspritze
Prevenar 20, Injektionssuspension in einer Fertigspritze
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
09/07/2025
Summary of Product Characteristics
Français
09/07/2025
Summary of Product Characteristics
Italien
09/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
4.4 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
2.2 UG Substance Wirkstoff (Principe actif)
(N/A)
46.2 UG Substance WIIS
(N/A)
51.0 UG Substance WIIS
(N/A)
0.125 MG Substance HIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.73 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 80.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2024

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
69222
Drug name
Prevenar 20, Injektionssuspension in einer Fertigspritze
Galenic form
INJFS
ATC Code
J07AL02
Authorization status
Z
Dispensing category
B
First authorization
26/03/2024
Authorization expiration date
25/03/2029
IT Number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Pneumokokken-Infektionen der Serotypen 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F

Package details

Description (FR)
PREVENAR 20 susp inj ser pré 0.5 ml
Description (DE)
PREVENAR 20 Inj Susp Fertspr 0.5 ml
Market launch
26/03/2024
Narcotic (BTM)
No

Other package sizes (1)

PREVENAR 20 susp inj 10 ser pré 0.5 ml
10 FESP
GTIN: 7680692220028
View